Vedolizumab (VDZ) for UC and CD: Still Safe and Effective After All These Years

Dig Dis Sci. 2020 Jul;65(7):1882-1884. doi: 10.1007/s10620-020-06212-7.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Arthralgia / drug therapy
  • Gastrointestinal Agents / adverse effects
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Referral and Consultation

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab